Page last updated: 2024-08-17

carbostyril and Weight Gain

carbostyril has been researched along with Weight Gain in 80 studies

Research

Studies (80)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (8.75)	18.2507
2000's	29 (36.25)	29.6817
2010's	41 (51.25)	24.3611
2020's	3 (3.75)	2.80

Authors

Authors	Studies
Chuang, YC; Hung, CC; Kuo, PH; Liu, WC; Sun, HY; Wu, PY	1
Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Sakuma, K	1
DeMarais, P; Max, B	1
Houwen, RHJ; Slae, M; van der Woerd, WL; Wilschanski, M	1
Baker, RA; Duffy, RA; Gwin, KK; McQuade, RD; Weiller, E; Weiss, C; Zhang, P	1
Eriksson, H; Newcomer, JW; Weiller, E; Weiss, C; Zhang, P	1
Bertolaso, C; Oberle, M; Sainath, N; Schall, JI; Stallings, VA	1
Chilvers, M; Cooke, J; Cunningham, S; Davies, JC; Harris, WT; Higgins, M; Lapey, A; Regelmann, WE; Rosenfeld, M; Sawicki, GS; Southern, KW; Tian, S	1
Aitchison, KJ; Almandil, NB; Besag, FM; Liu, Y; Murray, ML; Wong, IC	1
Baker, RA; Carson, W; Fleischhacker, WW; Forbes, RA; Jin, N; Johnson, B; Kane, JM; McQuade, R; Sanchez, R	1
Mueller, P; Rodman, D; Schmelz, A; Seliger, VI; Van Goor, F	1
Fuller, C; Grudziak, J; Nguyen, HL; Rickels, K; Rickels, MR; Teff, KL	1
Aida, SA; Hatim, A; Mohamed, Z; Reynolds, GP; Roffeei, SN; Said, MA; Zainal, NZ	1
Dai, G; Zhang, Y	1
Early, M; Erickson, CA; Horn, P; McDougle, CJ; Pottenger, A; Schaefer, T; Wink, LK	1
Baker, RA; Citrome, L; Hebden, T; Kalsekar, I	1
Barcessat, AR; Corrêa, L; de Cerqueira Luz, JG; Ferreira, LG; Huang, I; Rabelo, GD; Rosin, FC	1
De Santis, M; Deng, C; Huang, XF; Lian, J; Pan, B	1
Gu, N; Kane, JM; Li, H; Luo, J; Wang, C; Wang, X; Xie, S; Xu, X; Yu, W	1
Amado, JA; Ayesa-Arriola, R; Crespo-Facorro, B; Garcia-Unzueta, MT; Martínez García, O; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Tabares-Seisdedos, R	1
Borowitz, D; Davies, JC; Drevinek, P; Gilmartin, G; Griese, M; Jiang, Y; Konstan, MW; McKone, EF; Munck, A; Plant, B; Ratjen, F; Sermet-Gaudelus, I; Wainwright, C	1
Ahrens, R; Elborn, JS; Johnson, C; Konstan, MW; Munck, A; Plant, BJ; Rodriguez, S	1
Carson, WH; Correll, CU; Eriksson, H; Hobart, M; McQuade, RD; Nyilas, M; Ouyang, J; Pfister, S; Sanchez, R; Skuban, A	1
Bodewes, F; Borowitz, D; Gelfond, D; Lubarsky, B; Munck, A; Schwarzenberg, SJ; Wilschanski, M	1
Baker, RA; Citrome, L; Nagamizu, K; Ota, A; Perry, P; Weiller, E	1
Aigbogun, MS; Duffy, R; Hartry, A; Kamat, SA; Legacy, S; Sussman, M; Yu, J	1
Gallipani, A; Markovic, M; Maroney, M; Patel, KH	1
Chang, KD	1
Anderson, SJ; Brady, KT; McRae, AL; Tolliver, BK; Verduin, ML	1
Libiger, J; Masopust, J; Tůma, I	1
Carson, WH; Cutler, AJ; Keck, PE; Marcus, RN; McQuade, RD; Orsulak, PJ; Sanchez, R; Torbeyns, A	1
Bogers, JP; Starrenburg, FC	1
Englisch, S; Inta, D; Weinbrenner, A; Zink, M	1
Baker, RA; Berman, RM; Fava, M; Marcus, RN; Pikalov, A; Thase, ME; Tran, QV; Wisniewski, SR; Yang, H	1
Correll, CU; Kane, JM; Malhotra, AK; Manu, P; Napolitano, B; Olshanskiy, V	1
Carson, WH; Corey-Lisle, P; Findling, RL; Manos, G; Marcus, RN; McQuade, RD; Owen, R; Sikich, L	1
Stip, E; Tourjman, V	1
Roxanas, MG	1
Chen, J; Deng, C; Hu, C; Huang, XF	1
Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S	1
Case, M; Conley, RR; Hoffmann, VP; Jacobson, JG; Stauffer, VL	1
Correll, CU	1
Lee, SY; Pae, CU; Park, MH; Patkar, AA	1
Cohn, T; Faulkner, G; Mukundan, A; Remington, G	1
Bang, L; Harris, TB; Mian, A; Muscal, E	1
Hou, YC; Lai, CH	1
Carson, WH; Findling, RL; Kamen, L; Mankoski, R; Manos, G; Marcus, RN; McQuade, RD; Owen, R	1
Calabrese, JR; Demeter, CA; Findling, RL; Frazier, TW; Lingler, J; McNamara, NK; Otto, BD; Rowles, BM; Stansbrey, RJ; Youngstrom, EA	1
Berge, RK; Diéguez, C; Fernø, J; Fjær, S; López, M; Lunder, N; Pavlin, T; Skrede, S; Steen, VM; Vázquez, MJ; Vidal-Puig, A	1
Fava, M; Flynn, M; Harper, L; Iosifescu, D; Levy, M; Mischoulon, D; Pencina, M; Pollack, M; Rickels, K; Witte, J	1
Croxtall, JD	1
Chen, CK; Hsiao, CC; Huang, YS; Ree, SC; Wang, LJ	1
Alexopoulos, C; Kyriakis, CS; Kyriakis, SC; Papaioannou, DS; Polizopoulou, ZS; Tzika, ED	1
Bryois, Ch; Sahli, Ch	1
Citrome, L; Volavka, J	1
Archibald, D; Carson, WH; Gharbia, NA; Jody, D; Marcus, R; McQuade, RD; Stock, E; Vanveggel, S	1
Connor, KM; Davidson, JR; Gadde, KM; Payne, VM; Zhang, W	1
Britt, CS; Daniels, AJ; Grizzle, MK; Ignar, DM; Jones, DN; Kalinichev, M; Rourke, C	1
Bahta, E; Levine, S; Manas, K; Reddymasu, S; Slay, LE	1
Chen, CK; Lin, SK	1
Chavez, B; Poveda, RA	1
Banki, CM; Beuzen, JN; Hanssens, L; Herman, E; Kerwin, R; L'Italien, G; Lublin, H; McQuade, RD; Millet, B; Pans, M	1
Abbasi, FA; Glick, ID; Ivanova, O; Kim, SH; Lamendola, CA; Reaven, GM	1
Chen, CH; Huang, MC; Lu, ML	1
Cooper, T; Usubiaga, H; Winsberg, B	1
Perlis, RH	1
Neill, JC; Reynolds, GP; Snigdha, S; Thumbi, C	1
Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH	1
Burne, TH; Deng, C; Han, M; Huang, XF; Newell, KA	1
Close, R; Genicot, B; Lekeux, P; Lindsey, JK; Mouligneau, F; Rollin, F	1
Fujii, S; Furukawa, S; Kikumori, M; Morinaga, T; Shindo, Y; Sumi, N; Watanabe, M; Yasuhira, K	2
Fujii, S; Kikumori, M; Morinaga, T; Nishimori, T; Okazaki, I; Shindo, Y; Sumi, N; Watanabe, M	1
Fukuda, K; Iwakura, K; Nishimura, N; Shindo, Y; Sumi, N; Tamura, K; Yamazaki, S	1
Gunnarsson, A; Pedersen Mörner, A; Segall, T; Wallgren, P	1
Herrick, RL; Olchowy, TW; TerHune, TN	1
Bennejean, G; Cooper, AC; Gesbert, F; Guittet, M; Kempf, I	1

Reviews

17 review(s) available for carbostyril and Weight Gain

Article	Year
Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis. Psychopharmacology, 2020, Volume: 237, Issue:5 Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Network Meta-Analysis; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiophenes; Weight Gain	2020
Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis. Current opinion in pulmonary medicine, 2017, Volume: 23, Issue:6 Topics: Aminophenols; Aminopyridines; Benzodioxoles; Body Mass Index; Chloride Channel Agonists; Cystic Fibrosis; Digestive System; Drug Combinations; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Intestinal Diseases; Liver Diseases; Probiotics; Quinolones; Treatment Outcome; Weight Gain	2017
Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies. Current medical research and opinion, 2018, Volume: 34, Issue:12 Topics: Adult; Antipsychotic Agents; Clinical Trials, Phase III as Topic; Double-Blind Method; Glucose; Humans; Longitudinal Studies; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiophenes; Triglycerides; Weight Gain	2018
Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Paediatric drugs, 2013, Volume: 15, Issue:2 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Weight Gain	2013
A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults. Current medical research and opinion, 2014, Volume: 30, Issue:8 Topics: Adult; Antipsychotic Agents; Aripiprazole; Carbohydrate Metabolism; Diabetes Mellitus; Glucose Metabolism Disorders; Humans; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Overweight; Piperazines; Quinolones; Weight Gain	2014
Brexpiprazole. The Annals of pharmacotherapy, 2017, Volume: 51, Issue:4 Topics: Antidepressive Agents; Antipsychotic Agents; Clinical Trials, Phase III as Topic; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Thiophenes; Weight Gain	2017
The use of atypical antipsychotics in pediatric bipolar disorder. The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 4 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain	2008
How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. European psychiatry : the journal of the Association of European Psychiatrists, 2009, Volume: 24, Issue:3 Topics: Adiponectin; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Diabetes Mellitus; Humans; Leptin; Obesity; Olanzapine; Piperazines; Quinolones; Receptor, Muscarinic M3; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Histamine; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Weight Gain	2009
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Aripiprazole; Biomarkers; Blood Glucose; Body Mass Index; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Lipid Metabolism; Lipids; Logistic Models; Male; Metabolic Diseases; Middle Aged; Multicenter Studies as Topic; Obesity; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome; Waist Circumference; Weight Gain; Young Adult	2009
Aripiprazole in schizophrenia and schizoaffective disorder: A review. Clinical therapeutics, 2010, Volume: 32 Suppl 1 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Nausea; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Gain; Young Adult	2010
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophrenia research, 2010, Volume: 123, Issue:2-3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain	2010
Switching and combining antipsychotics. CNS spectrums, 2010, Volume: 15, Issue:4 Suppl 6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Decision Making; Female; Humans; Olanzapine; Piperazines; Polypharmacy; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Weight Gain	2010
Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems. The Cochrane database of systematic reviews, 2010, Dec-08, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Dibenzothiazepines; Drug Substitution; Fasting; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Schizophrenia; Weight Gain	2010
Aripiprazole: a review of its use in the management of schizophrenia in adults. CNS drugs, 2012, Feb-01, Volume: 26, Issue:2 Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Humans; Hyperglycemia; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Weight Gain	2012
[Psychotropics and weight gain]. Praxis, 2004, Aug-25, Volume: 93, Issue:35 Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain	2004
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning. Postgraduate medicine, 2004, Volume: 116, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain	2004
Treatment of bipolar disorder: the evolving role of atypical antipsychotics. The American journal of managed care, 2007, Volume: 13, Issue:7 Suppl Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain	2007

Trials

23 trial(s) available for carbostyril and Weight Gain

Article	Year
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB). Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019, Volume: 18, Issue:6 Topics: Aminophenols; Body Mass Index; Child, Preschool; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Ion Channel Gating; Liver Function Tests; Male; Pancreas; Quinolones; Sodium Chloride; Sweat; Transaminases; Treatment Outcome; Weight Gain	2019
Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia. International clinical psychopharmacology, 2013, Volume: 28, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Early Termination of Clinical Trials; Humans; Incidence; Injections, Intramuscular; Maintenance Chemotherapy; Middle Aged; Piperazines; Quinolones; Schizophrenia; Sleep Initiation and Maintenance Disorders; Weight Gain; Young Adult	2013
Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease. Diabetes, 2013, Volume: 62, Issue:9 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Eating; Female; Humans; Insulin Resistance; Male; Mental Disorders; Olanzapine; Piperazines; Postprandial Period; Quinolones; Weight Gain; Young Adult	2013
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone. Human psychopharmacology, 2014, Volume: 29, Issue:1 Topics: Adult; Alleles; Antipsychotic Agents; Aripiprazole; Body Mass Index; Female; Follow-Up Studies; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Piperazines; Polymorphism, Genetic; Quinolones; Receptors, Adrenergic, alpha-2; Schizophrenia; Thiazoles; Weight Gain; Weight Loss	2014
Efﬁcacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China. Human psychopharmacology, 2012, Volume: 27, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult	2012
Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trial. Schizophrenia research, 2014, Volume: 157, Issue:1-3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Blood Pressure; China; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Hyperprolactinemia; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Weight Gain	2014
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis. Schizophrenia research, 2014, Volume: 159, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Piperazines; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sex Factors; Thiazoles; Weight Gain	2014
Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST). The Lancet. Respiratory medicine, 2014, Volume: 2, Issue:11 Topics: Adolescent; Adult; Aminophenols; Child; Cough; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Female; Forced Expiratory Volume; Humans; Male; Mutation; Quinolones; Respiratory Tract Infections; Time Factors; Weight Gain; Young Adult	2014
Efficacy response in CF patients treated with ivacaftor: post-hoc analysis. Pediatric pulmonology, 2015, Volume: 50, Issue:5 Topics: Adolescent; Adult; Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Female; Forced Expiratory Volume; Humans; Male; Mutation; Numbers Needed To Treat; Quinolones; Respiratory Function Tests; Surveys and Questionnaires; Sweat; Weight Gain; Young Adult	2015
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial. The American journal of psychiatry, 2015, Sep-01, Volume: 172, Issue:9 Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Blood Glucose; Double-Blind Method; Female; Humans; Lipids; Male; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Thiophenes; Treatment Outcome; Weight Gain	2015
Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor. Digestive diseases and sciences, 2016, Volume: 61, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aminophenols; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Drug Administration Schedule; Female; Genetic Predisposition to Disease; Humans; Male; Membrane Transport Modulators; Mutation; Nutritional Status; Phenotype; Quinolones; Surveys and Questionnaires; Time Factors; Treatment Outcome; Weight Gain; Young Adult	2016
The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. International clinical psychopharmacology, 2016, Volume: 31, Issue:4 Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Quinolones; Schizophrenia; Serotonin Agents; Thiophenes; Treatment Outcome; Weight Gain	2016
Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. Journal of affective disorders, 2009, Volume: 112, Issue:1-3 Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Headache; Humans; Lithium Compounds; Male; Middle Aged; Nausea; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Treatment Outcome; Weight Gain	2009
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 2009, Volume: 124, Issue:6 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Personality Assessment; Piperazines; Quinolones; Treatment Outcome; Weight Gain	2009
Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controll Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Schizophrenia; Thiazoles; Time Factors; Triglycerides; Weight Gain	2010
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:9 Topics: Adolescent; Aggression; Alanine Transaminase; Antipsychotic Agents; Aripiprazole; Aspartate Aminotransferases; Autistic Disorder; Basal Ganglia Diseases; Child; Drug Tolerance; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Weight Gain	2011
An open-label study of aripiprazole in children with a bipolar disorder. Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Outpatients; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain	2011
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychotherapy and psychosomatics, 2012, Volume: 81, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Constipation; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Models, Statistical; Piperazines; Placebos; Quinolones; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; United States; Weight Gain; Young Adult	2012
A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 18 Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Female; Humans; Hyperlipidemias; Incidence; Lipids; Male; Obesity; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome; Weight Gain	2004
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:1 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Humans; Male; Nausea; Obesity; Obsessive-Compulsive Disorder; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain	2005
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study. European psychiatry : the journal of the Association of European Psychiatrists, 2007, Volume: 22, Issue:7 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Blood Glucose; Community Mental Health Services; Female; Humans; Lipoproteins; Male; Middle Aged; Patient Care; Piperazines; Prolactin; Quality of Life; Quinolones; Schizophrenia; Severity of Illness Index; Weight Gain	2007
Ghrelin and leptin response to oral glucose challenge among antipsychotic drug-treated children. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:6 Topics: Administration, Oral; Adolescent; Age Factors; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Blood Glucose; Body Mass Index; Child; Chlorpromazine; Fasting; Female; Ghrelin; Glucose; Glucose Tolerance Test; Humans; Insulin; Leptin; Male; Piperazines; Quinolones; Risperidone; Sex Factors; Time Factors; Weight Gain	2007
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment	2008

Other Studies

40 other study(ies) available for carbostyril and Weight Gain

Article	Year
Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 92 Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Dyslipidemias; Emtricitabine; Female; HIV Seropositivity; Humans; Lipids; Male; Middle Aged; Quinolones; Retrospective Studies; Tenofovir; Weight Gain	2020
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide discontinuation and return to normal weight. International journal of STD & AIDS, 2021, Volume: 32, Issue:1 Topics: Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Quinolones; Tenofovir; Weight Gain	2021
The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies. International clinical psychopharmacology, 2018, Volume: 33, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Female; Humans; Longitudinal Studies; Male; Meta-Analysis as Topic; Middle Aged; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiophenes; Weight Gain	2018
Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations. The Journal of pediatrics, 2018, Volume: 201 Topics: Adolescent; Adult; Aminophenols; Child; Child, Preschool; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA; DNA Mutational Analysis; Energy Metabolism; Female; Humans; Male; Middle Aged; Mutation; Quality of Life; Quinolones; Treatment Outcome; Weight Gain; Young Adult	2018
The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:6 Topics: Administration, Oral; Adolescent; Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Humans; Male; Mutation; Quinolones; Sensitivity and Specificity; Sweat; Weight Gain	2013
Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole. Journal of child and adolescent psychopharmacology, 2014, Volume: 24, Issue:2 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Body Mass Index; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Risperidone; Weight Gain; Young Adult	2014
Systemic toxic effects during early phases of topical 4-NQO-induced oral carcinogenesis in rats. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2014, Volume: 43, Issue:10 Topics: 4-Nitroquinoline-1-oxide; Administration, Topical; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Chemical Analysis; Carcinogenesis; Carcinogens; Female; Keratinocytes; Kidney Tubules; Leukocyte Count; Leukoplakia, Oral; Liver; Monocytes; Pancreas; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Quinolones; Rats; Rats, Wistar; Serum Albumin; Spleen; Submandibular Gland; Tongue; Tongue Neoplasms; Weight Gain	2014
Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats. Pharmacology, biochemistry, and behavior, 2014, Volume: 124 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Drinking Behavior; Feeding Behavior; Haloperidol; Male; Motor Activity; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Weight Gain	2014
Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder. Journal of affective disorders, 2017, Jan-01, Volume: 207 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Depressive Disorder, Major; Disorders of Excessive Somnolence; Drug Costs; Drug Therapy, Combination; Fatigue; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Olanzapine; Patient Selection; Quetiapine Fumarate; Quinolones; Serotonin Agents; Thiophenes; Weight Gain; Young Adult	2017
Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Diagnosis, Dual (Psychiatry); Humans; Hypertriglyceridemia; Mental Disorders; Piperazines; Quinolones; Substance-Related Disorders; Triglycerides; Weight Gain	2008
Adjunctive aripiprazole decreased metabolic side effects of clozapine treatment. Neuro endocrinology letters, 2008, Volume: 29, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Drug Therapy, Combination; Humans; Male; Piperazines; Quinolones; Schizophrenia, Paranoid; Weight Gain	2008
Aripiprazole for the management of olanzapine-induced weight gain. Pharmacopsychiatry, 2009, Volume: 42, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Central Nervous System Agents; Cholesterol; Drug Therapy, Combination; Female; Glucose; Humans; Male; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Treatment Outcome; Triglycerides; Weight Gain	2009
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, 2009, Oct-28, Volume: 302, Issue:16 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Child; Child, Preschool; Cohort Studies; Dibenzothiazepines; Female; Humans; Lipid Metabolism; Lipids; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Weight Gain	2009
Pathological gambling and compulsive eating associated with aripiprazole. The Australian and New Zealand journal of psychiatry, 2010, Volume: 44, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Compulsive Behavior; Dose-Response Relationship, Drug; Eating; Female; Gambling; Humans; Middle Aged; Piperazines; Quinolones; Receptors, Dopamine D3; Schizophrenia; Weight Gain	2010
Second-generation antipsychotics cause weight gain in youths. The Harvard mental health letter, 2010, Volume: 26, Issue:7 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Dibenzothiazepines; Humans; Olanzapine; Overweight; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Weight Gain	2010
What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity? Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Controlled Clinical Trials as Topic; Double-Blind Method; Humans; Obesity; Olanzapine; Piperazines; Quinolones; Schizophrenia; Weight Gain	2010
A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Mar-30, Volume: 35, Issue:2 Topics: Age Factors; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Female; Humans; Inpatients; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; Weight Gain	2011
Use of aripiprazole in adolescents with a history of lupus-associated psychosis and refractory psychiatric manifestations. Journal of psychiatric practice, 2011, Volume: 17, Issue:3 Topics: Adolescent; Adrenal Cortex Hormones; Antipsychotic Agents; Aripiprazole; Dyslipidemias; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Neuropsychological Tests; Piperazines; Psychotic Disorders; Quinolones; Remission Induction; Treatment Outcome; Weight Gain	2011
Aripiprazole-related body-weight gain and nutritional counseling. The Journal of neuropsychiatry and clinical neurosciences, 2011,Spring, Volume: 23, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Piperazines; Quinolones; Schizophrenia; Weight Gain	2011
Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:2 Topics: Adipose Tissue; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Female; Gene Expression Regulation; Hyperphagia; Lipid Metabolism; Lipogenesis; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Triglycerides; Weight Gain	2012
Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs. Progress in neuro-psychopharmacology & biological psychiatry, 2013, Jan-10, Volume: 40 Topics: Adiponectin; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Female; Humans; Lipids; Male; Middle Aged; Obesity; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quinolones; Weight Gain	2013
A field study on the effect of the dietary use of a clinoptilolite-rich tuff, alone or in combination with certain antimicrobials, on the health status and performance of weaned, growing and finishing pigs. Research in veterinary science, 2004, Volume: 76, Issue:1 Topics: Animals; Anti-Infective Agents; Diarrhea; Diet; Energy Intake; Enrofloxacin; Fluoroquinolones; Pyrans; Quinolones; Swine; Swine Diseases; Weaning; Weight Gain; Zeolites	2004
[Expectations and developments in atypical antipsychotics]. Praxis, 2004, Aug-25, Volume: 93, Issue:35 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Clozapine; Diabetes Complications; Haloperidol; Humans; Obesity; Olanzapine; Piperazines; Quinolones; Risk Factors; Schizophrenia; Weight Gain	2004
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology, 2005, Volume: 182, Issue:2 Topics: Animals; Aripiprazole; Benzodiazepines; Body Weight; Cholesterol, HDL; Fatty Acids, Nonesterified; Female; Olanzapine; Piperazines; Prolactin; Quinolones; Rats; Rats, Sprague-Dawley; Rats, Wistar; Weight Gain	2005
Second generation antipsychotics--aripiprazole revisited. The Medical letter on drugs and therapeutics, 2005, Oct-10, Volume: 47, Issue:1219 Topics: Antipsychotic Agents; Aripiprazole; Costs and Cost Analysis; Economics, Pharmaceutical; Humans; Piperazines; Quinolones; Schizophrenia; Weight Gain	2005
Elevated lipase and diabetic ketoacidosis associated with aripiprazole. JOP : Journal of the pancreas, 2006, May-09, Volume: 7, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetic Ketoacidosis; Humans; Lipase; Male; Piperazines; Quinolones; Schizophrenia; Weight Gain	2006
Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:8 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyslipidemias; Female; Humans; Hyperprolactinemia; Obesity; Piperazines; Quinolones; Risperidone; Schizophrenia, Paranoid; Treatment Outcome; Weight Gain	2006
Efficacy with high-dose aripiprazole after olanzapine-related metabolic disturbances. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Humans; Male; Metabolic Diseases; Olanzapine; Piperazines; Quinolones; Schizophrenia; Weight Gain	2006
Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:4 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Lipids; Lipoproteins; Male; Metabolism; Middle Aged; Pilot Projects; Piperazines; Quality of Life; Quinolones; Risk Factors; Schizophrenia; Schizophrenic Psychology; Weight Gain	2007
Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Appetite; Aripiprazole; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Male; Metabolic Diseases; Obesity; Olanzapine; Piperazines; Quinolones; Schizophrenia; Weight Gain	2007
Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:5 Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Eating; Female; Hyperphagia; Motor Activity; Olanzapine; Piperazines; Quinolones; Rats; Thiazoles; Weight Gain	2008
Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Psychoneuroendocrinology, 2008, Volume: 33, Issue:5 Topics: Adipose Tissue; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Eating; Female; Haloperidol; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; RNA, Messenger; Time Factors; Ventromedial Hypothalamic Nucleus; Weight Gain	2008
Economic, clinical and functional consequences of a treatment using metrenperone during an outbreak of shipping fever in cattle. The Veterinary record, 1993, Mar-06, Volume: 132, Issue:10 Topics: Animals; Anti-Infective Agents; Cattle; Disease Outbreaks; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Injections, Intramuscular; Male; Pasteurellosis, Pneumonic; Piperidines; Quinolones; Respiration; Respiratory Function Tests; Weight Gain	1993
[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(2)--A teratogenicity study in rats by oral administration]. The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1 Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Cecum; Dioxolanes; Drinking; Eating; Embryonic and Fetal Development; Female; Fluoroquinolones; Kidney; Male; Organ Size; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Reproduction; Weight Gain	1996
[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(3)--A teratogenicity study in rabbits by oral administration]. The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1 Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Cecum; Dioxolanes; Drinking; Eating; Embryonic and Fetal Development; Female; Fetal Death; Fluoroquinolones; Humans; Male; Organ Size; Piperazines; Pregnancy; Quinolones; Rabbits; Reproduction; Weight Gain	1996
[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(4)--A perinatal and postnatal study in rats by oral administration]. The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1 Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Infective Agents; Cecum; Dioxolanes; Drinking; Eating; Embryonic and Fetal Development; Female; Fluoroquinolones; Lactation; Male; Organ Size; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Reproduction; Weight Gain	1996
[A 4-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 4-week recovery test]. The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1 Topics: Administration, Oral; Animals; Anti-Infective Agents; Cecum; Chlorides; Dioxolanes; Drinking; Eating; Female; Fluoroquinolones; gamma-Globulins; Kidney Tubular Necrosis, Acute; Male; Organ Size; Piperazines; Potassium; Quinolones; Rats; Rats, Sprague-Dawley; Weight Gain	1996
Experimental infections with Actinobacillus pleuropneumoniae in pigs--I. Comparison of five different parenteral antibiotic treatments. Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B, 1999, Volume: 46, Issue:4 Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Weight; Cephalosporins; Diterpenes; Enrofloxacin; Fluoroquinolones; Lung; Lung Diseases; Penicillins; Quinolones; Swine; Swine Diseases; Weight Gain	1999
Efficacy of difloxacin in calves experimentally infected with Mannheimia haemolytica. American journal of veterinary research, 2000, Volume: 61, Issue:6 Topics: Animals; Anti-Infective Agents; Body Temperature; Cattle; Cattle Diseases; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Lung; Male; Mannheimia haemolytica; Pasteurella Infections; Quinolones; Random Allocation; Weight Gain	2000
Efficacy of danofloxacin in the therapy of experimental mycoplasmosis in chicks. Research in veterinary science, 1992, Volume: 53, Issue:2 Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Male; Mycoplasma Infections; Poultry Diseases; Quinolones; Respiratory Tract Infections; Tylosin; Weight Gain	1992